| Income Statement | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|
| Revenues | 105 | NaN | NaN | NaN |
| Cost of revenues | 103 | NaN | NaN | NaN |
| Gross profit | 2 | NaN | NaN | NaN |
| Research and development, net | 1,293 | 1,360* | 1,171 | 2,111 |
| Sales, general and administrative | 3,029 | 1,769* | 2,690 | 1,612 |
| Operating loss | -4,320 | -3,129* | -3,861 | -3,723 |
| Other income (see note 3g) | NaN | NaN | NaN | 0 |
| Financing income, net | 649 | 525* | 284 | 223 |
| Other income | NaN | 79* | NaN | NaN |
| Net loss | -3,671 | -2,526 | -3,577 | -3,500 |
| Basic EPS | -0.05 | -0.048 | -0.07 | -0.1 |
| Diluted EPS | -0.05 | -0.048 | -0.07 | -0.1 |
| Basic Average Shares | 67,158,044 | 52,787,688 | 48,095,384 | 36,488,014 |
| Diluted Average Shares | 67,158,044 | 52,787,688 | 48,095,384 | 36,488,014 |
Microbot Medical Inc. (MBOT)
Microbot Medical Inc. (MBOT)